(Q45411339)

English

Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases.

scientific article published in November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Feng-Chiao Tsai

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Jou-Wei Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Ming-Yang Lai

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Jun-Herng Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Ding-Shinn Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Liver International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1087-1094

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Treatment of patients with hepatitis C and normal serum aminotransferase levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Therapy of hepatitis C: patients with normal aminotransferase levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Clinical management of HCV carriers with normal aminotransferase levels.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Noninvasive diagnosis of fibrosis: the truth is rarely pure and never simple

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Updated definitions of healthy ranges for serum alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01355.X

21 January 2018

Identifiers

10.1111/J.1478-3231.2006.01355.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17032409%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45411339&oldid=1513993953"